Nuray Chemicals is an API manufacturer based in India. It holds 11 active US drug master files and 2 valid CEPs across a filed portfolio of 10 molecules. Its GMP standing is certified by MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 25 June 2024 as NAI. Customs aggregates show $12.3M of exports covering 323 molecules to 27 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Tiruvallur, India | 3006098295 |
| Thiruvallur, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Pitolisant | US FDA | 3 |
| Alosetron | US FDA | 2 |
| Tetraferric Tricitrate Decahydrate | US FDA | 2 |
| Acebutolol | EDQM | 1 |
| Atovaquone | US FDA | 1 |
| Benazepril | US FDA | 1 |
| Carglumic Acid | SFDA (Saudi Arabia) | 1 |
| Dapsone | EDQM | 1 |
| Glycerol Phenylbutyrate | US FDA | 1 |
| Tranylcypromine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 1 | None |
| MFDS (Korea) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.8M | 11 |
| 2025 | Not reported | $12.3M | 27 |
| 2024 | Not reported | $6.2M | 32 |
| 2023 | Not reported | $6.7M | 29 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Nuray Chemicals comes back tiered against every other supplier able to file there.
Start for free